Skip to main content

Table 3 GLM model for 4-week validated quit; adjusted odds ratios with 95 % confidence intervals (CI) and significance results

From: Gender difference and effect of pharmacotherapy: findings from a smoking cessation service

Variable Level Quit rate – n/N (%) Odds ratio (95 % CI) Wald (d.f.) p-value
Sex     6.7 (1) 0.01
Male 1763/3055 (57.7 %) 1   
Female 2133/3904 (54.6 %) 0.88 (0.79–0.97)   0.03
Region     192.9 (3) <0.001
East Sussex 2431/3773 (64.4 %) 1   
Sandwell 1069/2331 (45.9 %) 0.49 (0.44–0.55)   <0.001
Walsall 57/140 (40.7 %) 0.38 (0.27–0.54)   <0.001
Worcestershire 339/715 (47.4 %) 0.48 (0.40–0.57)   <0.001
Age     53.5 (4) <0.001
12–19 148/426 (34.7 %) 1   
20–29 553/1041 (53.1 %) 1.79 (1.39–2.31)   <0.001
30–49 1690/2963 (57.0 %) 2.12 (1.68–2.68)   <0.001
50–69 1275/2158 (59.1 %) 2.30 (1.80–2.92)   <0.001
70+ 230/371 (62.0 %) 2.47 (1.81–3.37)   <0.001
Counselling     71.7 (6) <0.001
One-to-one 3315/5666 (58.5 %) 1   
Drop-in 148/350 (42.3 %) 1.14 (0.88–1.47)   0.4
GP 155/326 (47.5 %) 0.89 (0.70–1.14)   0.2
Pharmacy 82/207 (39.6 %) 0.55 (0.41–0.73)   <0.001
Nurse 64/165 (38.8 %) 0.31 (0.22–0.42)   <0.001
Telephone 108/185 (58.4 %) 1.01 (0.75–1.37)   0.6
Other 24/57 (42.1 %) 0.55 (0.32–0.94)   0.02
Treatment     19.0 (1) <0.001
NRT 3340/6085 (54.9 %) 1   
Varenicline 556/874 (63.6 %) 1.41   <0.001